Genomic Health Inc. | Cash Flow
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
12,757.00
24,592.00
33,308.00
13,919.00
3,857.00
25,677
Depreciation, Depletion & Amortization
6,324.00
6,870.00
7,069.00
8,933.00
11,759.00
12,669
Other Funds
-
3,647.00
3,842.00
3,469.00
4,697.00
26,476
Funds from Operations
12,560.00
630.00
10,904.00
12,998.00
27,490.00
64,822
Changes in Working Capital
4,008.00
2,917.00
927.00
458.00
3,103.00
11,740
Net Operating Cash Flow
8,552.00
2,287.00
11,831.00
13,456.00
30,593.00
76,562
Capital Expenditures
10,992.00
10,455.00
23,483.00
19,786.00
13,276.00
Sale of Fixed Assets & Businesses
-
122.00
70.00
8.00
10.00
Purchase/Sale of Investments
8,986.00
3,890.00
29,696.00
652.00
29,292.00
Net Investing Cash Flow
7,006.00
14,223.00
6,283.00
19,126.00
42,558.00
Net Financing Cash Flow
13,728.00
8,383.00
8,355.00
13,541.00
17,079.00
Net Change in Cash
15,274.00
3,553.00
2,807.00
7,871.00
5,114.00
Free Cash Flow
2,440.00
8,168.00
35,314.00
6,330.00
17,317.00
Deferred Taxes & Investment Tax Credit
-
-
1,548.00
-
820.00
-
Change in Capital Stock
13,728.00
12,030.00
12,197.00
17,010.00
21,776.00
Other Uses
5,000.00
-
-
-
-
About Genomic Health
View Profile
